U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07057414) titled 'The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels' on June 26.
Brief Summary: This is a randomized, double-blind, placebo-controlled, single-center Phase IIa clinical study.
Study Start Date: July 07
Study Type: INTERVENTIONAL
Condition:
Cadmium Exceeds the Standard
Intervention:
DRUG: GMDTC for injection
GMDTC for Injection with a specification of 0.5g/vial, and administered by intravenous infusion. According to the drug preparation SOP , Using 0.9% physiological saline to achieve the required concentration for each dose group (e.g., The initial dose group: 2 g reconstituted in 500 mL, w...